NVAX logo

Novavax (NVAX) Total Liabilities

Annual Total Liabilities

$2.51 B
-$378.34 M-13.08%

December 31, 2023


Summary


Performance

NVAX Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Quarterly Total Liabilities

$2.24 B
-$11.43 M-0.51%

September 30, 2024


Summary


Performance

NVAX Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

NVAX Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.1%-4.1%
3 y3 years+163.2%-23.6%
5 y5 years+568.9%+536.0%

NVAX Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.1%at low-26.4%+0.8%
5 y5-year-14.1%+600.5%-26.4%+536.0%
alltimeall time-14.1%>+9999.0%-26.4%>+9999.0%

Novavax Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$2.24 B(-0.5%)
Jun 2024
-
$2.25 B(+1.3%)
Mar 2024
-
$2.22 B(-11.7%)
Dec 2023
$2.51 B(-13.1%)
$2.51 B(+7.7%)
Sep 2023
-
$2.34 B(-4.3%)
Jun 2023
-
$2.44 B(+0.1%)
Mar 2023
-
$2.44 B(-15.7%)
Dec 2022
$2.89 B(-1.2%)
$2.89 B(+2.1%)
Sep 2022
-
$2.83 B(-6.8%)
Jun 2022
-
$3.04 B(+9.8%)
Mar 2022
-
$2.77 B(-5.4%)
Dec 2021
$2.93 B(+206.6%)
$2.93 B(+39.1%)
Sep 2021
-
$2.10 B(+5.0%)
Jun 2021
-
$2.00 B(+27.7%)
Mar 2021
-
$1.57 B(+64.3%)
Dec 2020
$955.27 M(+166.1%)
$955.27 M(+14.1%)
Sep 2020
-
$837.58 M(+12.0%)
Jun 2020
-
$747.70 M(+112.4%)
Mar 2020
-
$352.04 M(-1.9%)
Dec 2019
$358.97 M(-4.5%)
$358.97 M(+1.2%)
Sep 2019
-
$354.65 M(-5.4%)
Jun 2019
-
$374.88 M(+0.8%)
Mar 2019
-
$371.90 M(-1.1%)
Dec 2018
$375.91 M(-7.0%)
$375.91 M(-0.3%)
Sep 2018
-
$377.16 M(+1.0%)
Jun 2018
-
$373.51 M(-0.5%)
Mar 2018
-
$375.44 M(-7.1%)
Dec 2017
$404.23 M(+1.1%)
$404.23 M(-1.0%)
Sep 2017
-
$408.23 M(-1.6%)
Jun 2017
-
$414.77 M(+6.2%)
Mar 2017
-
$390.60 M(-2.3%)
Dec 2016
$399.85 M(+328.2%)
$399.85 M(-2.4%)
Sep 2016
-
$409.84 M(-1.2%)
Jun 2016
-
$414.89 M(+1.9%)
Mar 2016
-
$407.07 M(+336.0%)
Dec 2015
$93.37 M(+101.3%)
$93.37 M(+148.2%)
Sep 2015
-
$37.62 M(+1.4%)
Jun 2015
-
$37.09 M(-5.2%)
Mar 2015
-
$39.13 M(-15.6%)
Dec 2014
$46.38 M(+45.4%)
$46.38 M(+50.3%)
Sep 2014
-
$30.86 M(+2.0%)
Jun 2014
-
$30.26 M(+9.9%)
Mar 2014
-
$27.54 M(-13.6%)
Dec 2013
$31.89 M(+44.3%)
$31.89 M(+11.9%)
Sep 2013
-
$28.50 M(+20.3%)
Jun 2013
-
$23.69 M(+12.1%)
Mar 2013
-
$21.14 M(-4.4%)
Dec 2012
$22.11 M(+73.7%)
$22.11 M(+15.3%)
Sep 2012
-
$19.17 M(+20.6%)
Jun 2012
-
$15.90 M(+11.1%)
Mar 2012
-
$14.31 M(+12.5%)
Dec 2011
$12.73 M(-19.4%)
$12.73 M(+1.9%)
Sep 2011
-
$12.49 M(-4.5%)
Jun 2011
-
$13.07 M(-21.3%)
Mar 2011
-
$16.61 M(+5.1%)
Dec 2010
$15.79 M
$15.79 M(+28.2%)
Sep 2010
-
$12.32 M(+7.9%)
DateAnnualQuarterly
Jun 2010
-
$11.42 M(-6.7%)
Mar 2010
-
$12.24 M(-21.8%)
Dec 2009
$15.65 M(-49.7%)
$15.65 M(+76.6%)
Sep 2009
-
$8.86 M(-34.3%)
Jun 2009
-
$13.50 M(-55.3%)
Mar 2009
-
$30.17 M(-3.1%)
Dec 2008
$31.14 M(+10.3%)
$31.14 M(-6.7%)
Sep 2008
-
$33.39 M(-0.5%)
Jun 2008
-
$33.56 M(+10.3%)
Mar 2008
-
$30.43 M(+7.8%)
Dec 2007
$28.23 M(+1.3%)
$28.23 M(+1.4%)
Sep 2007
-
$27.82 M(+0.2%)
Jun 2007
-
$27.78 M(-1.8%)
Mar 2007
-
$28.28 M(+1.4%)
Dec 2006
$27.88 M(-19.7%)
$27.88 M(+6.2%)
Sep 2006
-
$26.24 M(-1.9%)
Jun 2006
-
$26.75 M(+1.6%)
Mar 2006
-
$26.33 M(-24.2%)
Dec 2005
$34.73 M(-22.3%)
$34.73 M(-14.6%)
Sep 2005
-
$40.64 M(-2.3%)
Jun 2005
-
$41.60 M(-1.4%)
Mar 2005
-
$42.18 M(-5.7%)
Dec 2004
$44.71 M(-7.3%)
$44.71 M(+1.5%)
Sep 2004
-
$44.06 M(-14.1%)
Jun 2004
-
$51.28 M(+6.7%)
Mar 2004
-
$48.05 M(-0.3%)
Dec 2003
$48.22 M(-2.5%)
$48.22 M(-1.1%)
Sep 2003
-
$48.73 M(+2.0%)
Jun 2003
-
$47.79 M(-1.1%)
Mar 2003
-
$48.34 M(-2.2%)
Dec 2002
$49.43 M(+24.8%)
$49.43 M(+0.5%)
Sep 2002
-
$49.19 M(-2.2%)
Jun 2002
-
$50.27 M(+26.1%)
Mar 2002
-
$39.86 M(+0.6%)
Dec 2001
$39.62 M(+60.4%)
$39.62 M(+2.0%)
Sep 2001
-
$38.83 M(+38.2%)
Jun 2001
-
$28.10 M(+16.8%)
Mar 2001
-
$24.06 M(-2.6%)
Dec 2000
$24.70 M(+1353.2%)
$24.70 M(+1118.8%)
Sep 2000
-
$2.03 M(+18.3%)
Jun 2000
-
$1.71 M(+21.9%)
Mar 2000
-
$1.41 M(-17.3%)
Dec 1999
$1.70 M(+112.5%)
$1.70 M(+70.0%)
Sep 1999
-
$1.00 M(+233.3%)
Jun 1999
-
$300.00 K(-66.7%)
Mar 1999
-
$900.00 K(+12.5%)
Dec 1998
$800.00 K(+166.7%)
$800.00 K(+300.0%)
Sep 1998
-
$200.00 K(-33.3%)
Jun 1998
-
$300.00 K(0.0%)
Mar 1998
-
$300.00 K(0.0%)
Dec 1997
$300.00 K(-50.0%)
$300.00 K(+50.0%)
Sep 1997
-
$200.00 K(-60.0%)
Jun 1997
-
$500.00 K(+25.0%)
Mar 1997
-
$400.00 K(-33.3%)
Dec 1996
$600.00 K
$600.00 K(+50.0%)
Sep 1996
-
$400.00 K(-20.0%)
Jun 1996
-
$500.00 K(0.0%)
Mar 1996
-
$500.00 K

FAQ

  • What is Novavax annual total liabilities?
  • What is the all time high annual total liabilities for Novavax?
  • What is Novavax annual total liabilities year-on-year change?
  • What is Novavax quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Novavax?
  • What is Novavax quarterly total liabilities year-on-year change?

What is Novavax annual total liabilities?

The current annual total liabilities of NVAX is $2.51 B

What is the all time high annual total liabilities for Novavax?

Novavax all-time high annual total liabilities is $2.93 B

What is Novavax annual total liabilities year-on-year change?

Over the past year, NVAX annual total liabilities has changed by -$378.34 M (-13.08%)

What is Novavax quarterly total liabilities?

The current quarterly total liabilities of NVAX is $2.24 B

What is the all time high quarterly total liabilities for Novavax?

Novavax all-time high quarterly total liabilities is $3.04 B

What is Novavax quarterly total liabilities year-on-year change?

Over the past year, NVAX quarterly total liabilities has changed by -$96.59 M (-4.14%)